SLC5A5 and Familial prostate cancer: A quantitative evaluation of NIS protein levels, using more sensitive methods than immunohistochemistry, will provide more details on the role of NIS as biomarker for prostate cancer aggressiveness, as reported for beta-catenin using fluorescence microscopy[71].